U. K. Scientists Fear Government Will Muzzle Research Reports

New Rules Seen As Serious Threats To Academic Freedom LONDON--Gerald Draper is a worried man. Head of the Childhood Cancer Research Group at Oxford University, he often speaks at meetings of parents who live near nuclear installations, helping them understand why the risk of radiation-induced leukemia in their children is small. It is a daunting task, because the question of whether leukemia rates rise around nuclear power plants is one of the most contentious scientific issues in Britain.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

LONDON--Gerald Draper is a worried man. Head of the Childhood Cancer Research Group at Oxford University, he often speaks at meetings of parents who live near nuclear installations, helping them understand why the risk of radiation-induced leukemia in their children is small.

It is a daunting task, because the question of whether leukemia rates rise around nuclear power plants is one of the most contentious scientific issues in Britain. But now, the British government has made Draper’s job even more difficult. It is trying to make him sign a contract that could prevent him from publishing his work. If his research showed even small clusters of leukemia, would the government muzzle him, Draper wonders? And if so, what parent would ever believe that he is telling the truth about nuclear power? The new research contracts, say Draper and scores of other scientists across Britain, represent an ominous and serious threat ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Richard Smith

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo